Clinical Trial Update: Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update indicates that DA-001 is being studied in Phase 2/3 for reducing hair shedding and promoting hair regrowth, with the trial currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgenetic Alopecia
• Female Pattern Hair Loss
• Male Pattern Baldness
• Telogen Effluvium

Drugs mentioned

• DA-001

Snippet

Sponsor: Applied Biology, Inc. | Conditions: Telogen Effluvium, Female Pattern Hair Loss | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING